Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchtype 1 diabetesinsulinreview

Belgian review surveys new horizons in type 1 diabetes care

Revue Medicale de Liege authors outline emerging approaches in type 1 diabetes management, including therapeutic developments.

PR
By Priya Raman · Science Reporter
Aug 31 20:00 ETSource: Revue medicale de Liege

The wire

  1. 01A review in Revue Medicale de Liege examines new directions in type 1 diabetes.
  2. 02Type 1 diabetes remains a core target for insulin and peptide-based therapy.
  3. 03The excerpt does not specify which therapies are highlighted.

From the source

[Type 1 diabetes, towards new horizons]

Revue medicale de Liege · 2026 Sep · Wéra M, Rulmont J, Paquot N et al.

Read at pubmed.ncbi.nlm.nih.gov
Source URL https://pubmed.ncbi.nlm.nih.gov/42751841/